JP2012529506A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012529506A5 JP2012529506A5 JP2012514923A JP2012514923A JP2012529506A5 JP 2012529506 A5 JP2012529506 A5 JP 2012529506A5 JP 2012514923 A JP2012514923 A JP 2012514923A JP 2012514923 A JP2012514923 A JP 2012514923A JP 2012529506 A5 JP2012529506 A5 JP 2012529506A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- range
- chitosan
- composition according
- negatively charged
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001661 Chitosan Polymers 0.000 claims 7
- 150000004676 glycans Chemical class 0.000 claims 7
- 229920001282 polysaccharide Polymers 0.000 claims 7
- 239000005017 polysaccharide Substances 0.000 claims 7
- 208000003265 stomatitis Diseases 0.000 claims 4
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 3
- 229920000669 heparin Polymers 0.000 claims 3
- 229960002897 heparin Drugs 0.000 claims 3
- 238000011282 treatment Methods 0.000 claims 3
- 229920002971 Heparan sulfate Polymers 0.000 claims 2
- 206010028116 Mucosal inflammation Diseases 0.000 claims 1
- 201000010927 Mucositis Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 239000002518 antifoaming agent Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 229960000633 dextran sulfate Drugs 0.000 claims 1
- 238000006389 diacetylation reaction Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000001959 radiotherapy Methods 0.000 claims 1
- 238000009168 stem cell therapy Methods 0.000 claims 1
- 238000009580 stem-cell therapy Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0950441-6 | 2009-06-10 | ||
| SE0950441 | 2009-06-10 | ||
| PCT/SE2010/050650 WO2010144044A1 (en) | 2009-06-10 | 2010-06-10 | Use of a composition for the treatment of mucositis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012529506A JP2012529506A (ja) | 2012-11-22 |
| JP2012529506A5 true JP2012529506A5 (enExample) | 2013-07-25 |
Family
ID=43309105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012514923A Pending JP2012529506A (ja) | 2009-06-10 | 2010-06-10 | 粘膜炎治療用組成物の使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8906883B2 (enExample) |
| EP (1) | EP2440216A4 (enExample) |
| JP (1) | JP2012529506A (enExample) |
| CN (1) | CN102458419A (enExample) |
| AU (1) | AU2010259284A1 (enExample) |
| BR (1) | BRPI1009741A2 (enExample) |
| CA (1) | CA2763092A1 (enExample) |
| RU (1) | RU2011152518A (enExample) |
| WO (1) | WO2010144044A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2555760B1 (en) | 2010-04-06 | 2019-10-16 | Synedgen, Inc. | Chitosan derivatives for the treatment of mucositis or ulceration |
| CA2883704C (en) | 2012-09-20 | 2021-09-28 | Synedgen, Inc. | Methods for treatment or prevention of damage resulting from radiation, trauma or shock |
| WO2015022907A1 (ja) * | 2013-08-13 | 2015-02-19 | 生化学工業株式会社 | カチオン化キトサンを含有する医薬 |
| EP3060243A4 (en) * | 2013-10-22 | 2017-03-29 | Cantex Pharmaceuticals, Inc. | Methods of treating and preventing radiation damage |
| US20180228832A1 (en) * | 2015-08-18 | 2018-08-16 | Pharma Seeds Create, Llc | Stomatological composition containing nsaid or heparin compound |
| EP3787593A1 (en) * | 2018-05-04 | 2021-03-10 | Bonoss Medical Aktiebolag | A composition for reduction of scar formation |
| WO2019236453A1 (en) | 2018-06-03 | 2019-12-12 | Glycomira Therapeutics, Inc. | Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and /or chemotherapy |
| US20230181624A1 (en) * | 2020-04-24 | 2023-06-15 | Intact Therapeutics, Inc. | Compositions and methods for treatment of gastrointestinal bleeding |
| EP3981505B1 (en) * | 2020-10-12 | 2024-11-27 | Gambro Lundia AB | Membrane with immobilized anticoagulant and process for producing same |
| EP4401784A4 (en) * | 2021-09-17 | 2025-09-10 | Shawn Walker | USE OF CHITOSAN COMPLEXES OR COMPOSITIONS TO REDUCE THE INFILTRATION OF ENVIRONMENTAL FACTORS INTO THE BRAIN |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9402529D0 (sv) * | 1994-07-19 | 1994-07-19 | Astra Ab | Anti-adherensmedel |
| SE9402531L (sv) * | 1994-07-19 | 1996-01-20 | Medicarb Ab | Sårläkningsmedel |
| SE507028C2 (sv) | 1996-08-06 | 1998-03-16 | Medicarb Ab | Ny medicinsk användning |
| US6989156B2 (en) * | 2001-04-23 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Therapeutic treatments using the direct application of antimicrobial metal compositions |
| US7547433B2 (en) * | 2001-02-15 | 2009-06-16 | Access Pharmaceuticals, Inc. | Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| EP1539192A1 (en) | 2002-04-24 | 2005-06-15 | Medicarb AB | Composition and kit for the treatment of inflammatory bowel diseases |
| JP2006508075A (ja) * | 2002-10-07 | 2006-03-09 | オラファーマ， インコーポレイテッド | 粘膜付着性テトラサイクリン製剤 |
| AU2005285040A1 (en) * | 2004-09-14 | 2006-03-23 | Molecular Therapeutics, Inc. | D-methionine formulation with improved biopharmaceutical properties |
| US20080118542A1 (en) | 2005-01-19 | 2008-05-22 | Bonoss Medical Ab | Growth Factor Composition |
| DE102006024831B4 (de) | 2006-05-24 | 2008-03-27 | Heraeus Quarzglas Gmbh & Co. Kg | Verfahren zur Herstellung eines Halbzeugs aus synthetischem Quarzglas |
| US20080299050A1 (en) | 2006-10-05 | 2008-12-04 | Drugtech Corporation | Topical therapies for oral mucositis and other conditions |
-
2010
- 2010-06-10 RU RU2011152518/15A patent/RU2011152518A/ru not_active Application Discontinuation
- 2010-06-10 CA CA2763092A patent/CA2763092A1/en not_active Abandoned
- 2010-06-10 EP EP10786461.3A patent/EP2440216A4/en not_active Withdrawn
- 2010-06-10 WO PCT/SE2010/050650 patent/WO2010144044A1/en not_active Ceased
- 2010-06-10 AU AU2010259284A patent/AU2010259284A1/en not_active Abandoned
- 2010-06-10 CN CN2010800254173A patent/CN102458419A/zh active Pending
- 2010-06-10 JP JP2012514923A patent/JP2012529506A/ja active Pending
- 2010-06-10 BR BRPI1009741A patent/BRPI1009741A2/pt not_active IP Right Cessation
- 2010-06-10 US US13/376,947 patent/US8906883B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012529506A5 (enExample) | ||
| HRP20201578T1 (hr) | Formulacija rnk za imunoterapiju | |
| TN2014000236A1 (en) | Use of chemically modified heparin derivates in sickle cell disease | |
| MX2013012253A (es) | Conjugados novedosos de aglutinante-farmaco (adc) y su uso. | |
| MX2019000225A (es) | Composiciones y metodos para el tratamiento de enfermedades autoinmunes y otras enfermedades. | |
| NZ630560A (en) | Pharmaceutical compositions for combination therapy | |
| HK1203489A1 (en) | Purinone compounds as kinase inhibitors | |
| JP2014507482A5 (enExample) | ||
| IN2014MN02288A (enExample) | ||
| IL231536A (en) | Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases | |
| PL2571503T3 (pl) | Kompozycje i sposoby leczenia nowotworu, choroby zapalnej i innych zaburzeń | |
| BR112013025517A2 (pt) | uso de 2,3-diidroimidazo[1,2-c]quinazolinas substituídas | |
| EA202090662A2 (ru) | ПРОИЗВОДНЫЕ ПИРРОЛО[3,2-d]ПИРИМИДИНА ДЛЯ ЛЕЧЕНИЯ ВИРУСНЫХ ИНФЕКЦИЙ И ДРУГИХ ЗАБОЛЕВАНИЙ | |
| EA201500535A1 (ru) | Применение akkermansia muciniphila для лечения метаболических расстройств, увеличения расхода энергии и насыщения, снижения веса, композиция, фармацевтическая композиция, косметическая композиция и лекарственное средство | |
| MX351975B (es) | Composiciones y metodos para el tratamiento de infecciones y tumores. | |
| MX2015008481A (es) | Compuestos de [1,2,4]triazolo[1,5-c]quinazolin-5-amina heterobiciclo-sustituidos con propiedades antagonistas para a2a. | |
| JP2012036176A5 (enExample) | ||
| BR112014027971A2 (pt) | dispositivos médicos revestidos incluindo um agente terapêutico insolúvel em água | |
| RU2011152518A (ru) | Применение композиции для лечения мукозита | |
| EP2853543A8 (en) | Anti-blys antibody | |
| MX2011009651A (es) | Formulacion que comprende particulas de avermectina revestidas con agente fotoprotector. | |
| BR112014030534A2 (pt) | composições de galacto-ramnogalacturonato para o tratamento de doenças associadas com óxido nítrico sintase induzível elevada | |
| CL2013000677A1 (es) | Composicion farmaceutica en forma de tabletas que comprenden microgranulos gastrointestinales que contienen 100 a 800 mg de rifaximina, hasta 30% p/p de excipientes extragranulares y un recubrimiento formador de pelicula; y uso para tratar una enfermedad infecciosa y/o inflamatoria del intestino, tal como la enfermedad de crohn. | |
| EP2729148A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF SYMPTOMS IN PATIENTS WITH MORBUS PARKINSON | |
| MX2013011971A (es) | Tratamiento de enfermedades con nanofibras de poli-n-acetil-glucosamina. |